University of California San Francisco
Give to UCSF
Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
COVID-19 Vaccines Saved Dementia Patients’ Lives in Nursing Homes
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
What’s New in the Search for a Long COVID Cure?
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
Two UCSF Researchers Win Pew Awards for Biomedical Science
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.
Two New Vaccines Join the Fight to Eradicate Polio
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education.
COVID-19 Masks: Expert Tips for What You Should (and Shouldn’t) Do
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
Two UCSF Faculty Named to New Group of HHMI Scholars
UCSF faculty members Walter G. Gonzalez and Angela Phillips have been selected as Howard Hughes Medical Institute (HHMI) Freeman Hrabowski Scholars. With up to $8.6 million in support, they will conduct research, create inclusive lab environments, and make a significant impact on the future of science. Both scholars are committed to fostering diversity and promoting scientific breakthroughs.
Does Your Vaccine Type Matter in the Battle Against COVID?
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.
